Rhythm Pharmaceuticals (RYTM) Times Interest Earned: 2022-2025
Historic Times Interest Earned for Rhythm Pharmaceuticals (RYTM) over the last 3 years, with Sep 2025 value amounting to -$11.10.
- Rhythm Pharmaceuticals' Times Interest Earned fell 32.63% to -$11.10 in Q3 2025 from the same period last year, while for Sep 2025 it was -$8.70, marking a year-over-year increase of 37.29%. This contributed to the annual value of -$12.89 for FY2024, which is 2.89% up from last year.
- Per Rhythm Pharmaceuticals' latest filing, its Times Interest Earned stood at -$11.10 for Q3 2025, which was down 42.59% from -$7.79 recorded in Q2 2025.
- Rhythm Pharmaceuticals' 5-year Times Interest Earned high stood at -$7.57 for Q4 2024, and its period low was -$29.42 during Q1 2024.
- Over the past 3 years, Rhythm Pharmaceuticals' median Times Interest Earned value was -$9.07 (recorded in 2023), while the average stood at -$12.37.
- Its Times Interest Earned has fluctuated over the past 5 years, first slumped by 71.43% in 2024, then soared by 70.46% in 2025.
- Rhythm Pharmaceuticals' Times Interest Earned (Quarterly) stood at -$13.98 in 2022, then soared by 35.14% to -$9.07 in 2023, then rose by 16.49% to -$7.57 in 2024, then crashed by 32.63% to -$11.10 in 2025.
- Its Times Interest Earned was -$11.10 in Q3 2025, compared to -$7.79 in Q2 2025 and -$8.69 in Q1 2025.